Saudi Arabia Hemato Oncology Testing Market Size & Outlook
Saudi Arabia hemato oncology testing market, 2018-2028 (US$M)
Related Markets
Saudi Arabia hemato oncology testing market highlights
- The Saudi Arabia hemato oncology testing market generated a revenue of USD 17.0 million in 2020 and is expected to reach USD 41.5 million by 2028.
- The Saudi Arabia market is expected to grow at a CAGR of 11.8% from 2021 to 2028.
- In terms of segment, lymphoma was the largest revenue generating cancer type in 2020.
- Lymphoma is the most lucrative cancer type segment registering the fastest growth during the forecast period.
Hemato oncology testing market data book summary
| Market revenue in 2020 | USD 17.0 million |
| Market revenue in 2028 | USD 41.5 million |
| Growth rate | 11.8% (CAGR from 2020 to 2028) |
| Largest segment | Lymphoma |
| Fastest growing segment | Lymphoma |
| Historical data | 2018 - 2019 |
| Base year | 2020 |
| Forecast period | 2021 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Leukemia, Lymphoma, MPNs, Other Cancers |
| Key market players worldwide | Roche Holding AG, Abbott Laboratories, Qiagen NV, Danaher Corp, Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, Illumina Inc, Bio-Techne Corp |
Other key industry trends
- In terms of revenue, Saudi Arabia accounted for 0.7% of the global hemato oncology testing market in 2020.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2028.
- In Middle East & Africa, South Africa hemato oncology testing market is projected to lead the regional market in terms of revenue in 2028.
- South Africa is the fastest growing regional market in Middle East & Africa and is projected to reach USD 69.5 million by 2028.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Hemato Oncology Testing Market Scope
Hemato Oncology Testing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Saudi Arabia hemato oncology testing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hemato oncology testing market will help companies and investors design strategic landscapes.
Lymphoma was the largest segment with a revenue share of 45.88% in 2020. Horizon Databook has segmented the Saudi Arabia hemato oncology testing market based on leukemia, lymphoma, mpns, other cancers covering the revenue growth of each sub-segment from 2018 to 2028.
The increasing incidence of blood cancers in Saudi Arabia is expected to propel the demand for testing solutions over the forecast period. According to Globocan estimates, in 2020, around 1,676 new cases of leukemia, 1,698 new cases of non-Hodgkin lymphoma, 687 news cases of Hodgkin lymphoma, and 265 new cases of multiple myelomas were diagnosed reported in the Saudi Arabia.
In December 2018, OncoDNA, a Belgium-based medical company went into a strategic agreement with International Medical Center (IMC) located in Jeddah, Saudi Arabia. As per the agreement, OncoDNA will provide its full range of cancer diagnostic products to IMC.
Such strategic initiatives and increasing access to novel cancer diagnostic systems are expected to support market growth. Furthermore, in February 2019, the Saudi Arabia Ministry of Health celebrated International Childhood Cancer Day to provide support and increase awareness about the most common type of cancer including Leukemia, Hodgkin's lymphoma, and Non-Hodgkin's lymphoma.
Reasons to subscribe to Saudi Arabia hemato oncology testing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Saudi Arabia hemato oncology testing market databook
-
Our clientele includes a mix of hemato oncology testing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia hemato oncology testing market , including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia hemato oncology testing market from 2018 to 2028, including revenue numbers, major trends, and company profiles.
Partial client list
Saudi Arabia hemato oncology testing market size, by cancer type, 2018-2028 (US$M)
Saudi Arabia Hemato Oncology Testing Market Outlook Share, 2020 & 2028 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
